<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00103363</url>
  </required_header>
  <id_info>
    <org_study_id>92-0392</org_study_id>
    <secondary_id>UCHSC-92-392</secondary_id>
    <nct_id>NCT00103363</nct_id>
  </id_info>
  <brief_title>Sputum Cytology in Screening Heavy Smokers For Lung Cancer</brief_title>
  <official_title>Lung Cancer Screening and Tissue Procurement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      RATIONALE: Screening tests, such as sputum cytology, may help doctors find tumor cells early&#xD;
      and plan better treatment for lung cancer.&#xD;
&#xD;
      PURPOSE: This phase II trial is studying how well sputum cytology works in screening heavy&#xD;
      smokers for lung cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
      Primary&#xD;
&#xD;
        -  Classify annual sputum samples cytologically in participants with or without airflow&#xD;
           obstruction and a heavy smoking history.&#xD;
&#xD;
        -  Correlate sputum cytological atypia (moderate atypia or worse) with lung cancer&#xD;
           incidence in these participants.&#xD;
&#xD;
        -  Correlate changes in sputum cytology (i.e., changes toward higher grades of atypia) with&#xD;
           lung cancer incidence in these participants.&#xD;
&#xD;
      Secondary&#xD;
&#xD;
        -  Determine other risk factors for lung cancer (e.g., diet, family history, smoking&#xD;
           history, and medications) that may either confound or modify the association between&#xD;
           sputum cytology and lung cancer risk in these participants.&#xD;
&#xD;
      OUTLINE: Two 3-day pooled sputum samples are collected for 6 consecutive days from&#xD;
      participants by the spontaneous cough technique for cytopathological evaluation. Participants&#xD;
      also complete a risk factor questionnaire and undergo a pulmonary function test by spirometry&#xD;
      and a blood draw.&#xD;
&#xD;
      Participants complete a questionnaire updating smoking, vital, and lung cancer status and&#xD;
      undergo sputum sample collection annually.&#xD;
&#xD;
      Participants are informed of sputum cytology results.&#xD;
&#xD;
      PROJECTED ACCRUAL: A total of 3,400 participants (2,900 with airflow obstruction and 500&#xD;
      without airflow obstruction) will be accrued for this study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 1993</start_date>
  <completion_date type="Actual">February 1994</completion_date>
  <primary_completion_date type="Actual">February 1994</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Classification of annual sputum samples cytologically</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of sputum cytological atypia (moderate atypia or worse) with lung cancer incidence</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of changes in sputum cytology with lung cancer incidence</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk factors for lung cancer that may effect the association between sputum cytology and lung cancer risk</measure>
  </secondary_outcome>
  <enrollment type="Actual">3270</enrollment>
  <condition>Lung Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>cytology specimen collection procedure</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>physiologic testing</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>annual screening</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>study of high risk factors</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:&#xD;
&#xD;
          -  Current or ex-smoker with a lifetime history of cigarette smoking of ≥ 20 pack years,&#xD;
             meeting 1 of the following criteria:&#xD;
&#xD;
               -  Airflow obstruction&#xD;
&#xD;
                    -  FEV_1 &lt; 75% predicted for age by spirometry&#xD;
&#xD;
                    -  FEV_1/FVC ≤ 75% by spirometry&#xD;
&#xD;
               -  No airflow obstruction&#xD;
&#xD;
          -  No history of lung cancer&#xD;
&#xD;
        PATIENT CHARACTERISTICS:&#xD;
&#xD;
        Age&#xD;
&#xD;
          -  25 and over&#xD;
&#xD;
        Performance status&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Life expectancy&#xD;
&#xD;
          -  More than 5 years&#xD;
&#xD;
        Hematopoietic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Hepatic&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Renal&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Other&#xD;
&#xD;
          -  No cancer within the past 5 years except nonmelanoma skin cancer&#xD;
&#xD;
        PRIOR CONCURRENT THERAPY:&#xD;
&#xD;
        Biologic therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Chemotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Endocrine therapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Radiotherapy&#xD;
&#xD;
          -  Not specified&#xD;
&#xD;
        Surgery&#xD;
&#xD;
          -  Not specified&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Timothy Kennedy</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Colorado Health Sciences Center - Denver</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80262</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <study_first_submitted>February 7, 2005</study_first_submitted>
  <study_first_submitted_qc>February 7, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2005</study_first_posted>
  <last_update_submitted>May 5, 2014</last_update_submitted>
  <last_update_submitted_qc>May 5, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 7, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>non-small cell lung cancer</keyword>
  <keyword>small cell lung cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

